Quest Diagnostics To Acquire PathAI Diagnostics To Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements With PathAI
3BL Media
MAY 6, 2024
Under the terms of a definitive agreement, Quest will acquire select assets of PathAI Diagnostics, the business of PathAI that provides anatomic and digital pathology laboratory services. In addition, Quest will be a preferred provider for PathAI's biopharmaceutical clinical laboratory services.
Let's personalize your content